Help Your Clients Stop Loving Their Horses to Death

Author:
Publish date:

“Food is not love, especially when a horse is prone to EMS. Metabarol is quite useful in managing these horses.”--Dr. Peter Morresey, Rood & Riddle Equine Hospital, Lexington, Kentucky

For horses genetically predisposed to equine metabolic syndrome (EMS) or those horses that are obese, foundered or insulin resistant, Metabarol is proven to help!* Metabarol is scientifically proven to reduce insulin levels by 25-30% in horses diagnosed with EMS. Simple, daily dosing of 30 grams may reduce the risk of grass foundering in combination with diet and exercise.

Scientifically Tested and Proven to Work

Equithrive was built on science. Rigorous scientific testing at leading research institutions demonstrates our products’ safety and effectiveness. If you believe in products backed by scientific research, you can trust Equithrive products to support the health and performance of the horse.

Metabarol has been scientifically proven to reduce insulin levels and inflammation in horses previously diagnosed with EMS in studies performed at the Gluck Equine Research Center and funded by the American Quarter Horse Association. Review our research summaries, results and JEVS abstract at equithrive.com.

Metabarol is a premium scientific formula of our proprietary micro-encapsulated Resveratrol (Resverasyn) that is administered daily to support optimum metabolic function in horses. University-conducted research demonstrated that Metabarol reduced insulin levels by 25-30% after 45 days of administration in horses previously diagnosed with equine metabolic syndrome via the oral sugar test.

Improves Metabolic Efficiency

The active ingredient, Resveratrol, activates an enzyme called Sirtuin that causes an increase in the size and density of mitochondria, the body’s cellular powerhouse. This results in more efficient glucose metabolism.

Reduces Insulin Levels

The high levels of blood insulin associated with insulin resistance, known as hyperinsulinemia, can contribute to increased risk of laminitis, a devastating condition in the hoof.

Reduced Chronic Inflammation

Chronic inflammation decreases the sensitivity of insulin receptors to insulin, a condition referred to as insulin resistance (IR). Glucose is not readily transported into cells in animals with insulin resistance. To compensate for insulin resistance, the pancreas of IR animals typically produces and secretes larger amounts of insulin to promote entry of glucose into cells. High levels of blood insulin can contribute to increased risk of laminitis.

Daily Metabarol administration has been shown to decrease circulating levels of the pro-inflammatory mediator TNF-alpha in horses. The reduction in chronic inflammation associated with daily Metabarol administration improves insulin sensitivity in horses previously diagnosed with equine metabolic dyndrome. This improvement in insulin sensitivity explains the reduction in blood insulin levels in EMS horses exposed to the oral sugar test after 45 days of Metabarol administration.

Directions for Use: Administer 4 heaping scoops (30 grams) on a daily basis. For best results divide recommended daily dosage between morning and evening.

Active Ingredient: Resverasyn (Microencapsulated Resveratrol) 4,000mg per daily dose

Inactive Ingredients: Saccharomyces Cerevisiae 1026, Natural Molasses Flavor and Diatomaceous Earth

For more information visit Equithrive.com or contact Equithrive, 449 Lewis Hargett Circle, Suite 190, Lexington, KY 40503; 866-721-1412; info@equithrive.com

*Adams, A. A. (2013). Abstract Title. Journal of Equine Veterinary Science. Abstracts. 33 (321-300), pg. 343.